Meeting Medicaid's Cost and Quality Challenges: The Role of AHCPR Research


Contents

Introduction
Care for Elderly and Disabled Populations
Maternal and Child Health
Research and Technical Assistance on HIV and AIDS
Drug Policy
Informing Consumers
System Financing and Management
Conclusion
References


Introduction

The Federal Medicaid program provides a growing safety net for a broad cross-section of the population, and in particular for those with severe and costly health care needs. The program currently pays for a third of all births, finances health care for one in four American children, and covers 60 percent of the poor. Medicaid also pays for half of all nursing home care, subsidizes acute care for poor Medicare enrollees, and has a large and increasing responsibility for people with disabilities and AIDS (Rowland, 1995).

Finding a way to control costs and improve the quality of Medicaid services has provided a growing challenge for both Federal and State policymakers. Although Medicaid expenses in the past grew more slowly than private health care spending, program costs increased dramatically in the late 1980s and early 1990s, thanks to rapid eligibility expansion, a national recession, inflation in health care spending, and State use of statutory loopholes to leverage Federal dollars. Between fiscal years 1988 and 1993, annual Federal and State Medicaid expenditures rose from $54 billion to $131 billion. Between fiscal years 1994 and 1995 these expenditures rose from $144 billion to $159 billion (Personal Communication, Joseph Dunne, Health Care Financing Administration, April 28, 1997).

In part as an effort to control these costs, the Medicaid program has moved rapidly in the direction of managed care. By 1995, nearly one-third of Medicaid recipients (mostly poor children and their parents) were enrolled in some form of managed care (Rowland and Hanson, 1996). The hope is that these delivery changes can not only control costs but also improve the quality of care. Both the Health Care Financing Administration and the States are spending a great deal of time developing and implementing mechanisms to realize these hopes. The role of the Agency for Health Care Policy and Research (AHCPR) during this process has been to:

  1. Provide science-based research to support these Federal and State efforts.
  2. Disseminate research findings and guidelines that managed care plans and providers serving the Medicaid population can use to lower costs and improve quality.
  3. Provide technical assistance to State policymakers and administrators seeking to improve their Medicaid programs.

AHCPR also conducts the Medical Expenditure Panel Survey (MEPS), a source of data for policymakers and researchers on Medicaid. As a nationally representative survey, MEPS collects detailed information on Medicaid coverage, costs, utilization, and health status of Medicaid beneficiaries.

AHCPR research has addressed eight of the inpatient diagnoses and procedures most costly to the Medicaid program. Increasingly, research also has addressed outpatient and long-term care issues. AHCPR also supports 11 research centers that study patient outcomes and the effectiveness of medical treatment for conditions that disproportionately affect minority populations. Finally, through the User Liaison program, the Agency provides technical assistance to State policymakers and Medicaid officials who are attempting to design and implement changes in their programs.

As discussed below, AHCPR research and technical assistance falls into six areas of critical importance to the Medicaid program: care for elderly and disabled populations, maternal and child health, research and technical assistance on HIV and AIDS, drug policy, informing consumers, and system financing and management.

Return to Contents

Care for Elderly and Disabled Populations

Although only about a quarter of Medicaid recipients are elderly, blind, and/or disabled, this population accounts for almost 60 percent of program spending, about $62.6 billion in 1993 (Rowland, 1995). One reason these expenses are so high is that Medicaid pays for long-term care services, whereas Medicare for the most part does not. Long-term care accounts for about 35 percent of Medicaid costs, and most of these services go to the elderly, blind, and disabled (Rowland, 1995). Put another way, the Medicaid program pays for about half of all nursing home care in the U.S., with out-of-pocket payments accounting for most of the rest (Lair, 1992; Short et al., 1992, cited in Cohen and Spector, 1996). For this reason, AHCPR has devoted a large and growing part of its research effort to issues surrounding the payment and delivery of long-term care services and other services for the aged, blind, and disabled population. (For more information, select AHCPR Research on Long-Term Care).

In the early 1990s, a significant Agency activity was the development and dissemination of clinical practice guidelines. For example, acute pain, pressure ulcers, and urinary incontinence are conditions common to elderly and disabled patients in acute and long-term care settings. Providers adopting AHCPR guidelines in these areas report that they have been able to speed recovery, improve patient comfort, and reduce costs. Heritage Manor Nursing Home in Chattanooga, for example, used the incontinence and pressure ulcer prevention guidelines to increase the percentage of dry patients from under 33 percent to over 76 percent, and reduced the number of average pressure ulcers from 14 to 5 (AHCPR, 1996a).

For this reason, many States have helped with guideline dissemination and some have incorporated the guidelines into their quality review protocols. For example:

The American Medical Directors' Association (AMDA) adapted AHCPR-sponsored guidelines for long-term care use (the single greatest program cost for Medicaid) in five areas: prevention of adult urinary incontinence, evaluation and care for patients with potential heart failure, detection and treatment of depression, pressure ulcer prevention, and pressure ulcer treatment. This decision was endorsed by a steering committee of long-term care associations including the American Health Care Association, the American Association of Homes and Services for the Aging, and the American Society of Consultant Pharmacies. In 1997, AMDA is developing two guidelines, one on falls and one on altered mental states, that will use AHCPR's guideline on early Alzheimer's disease along with other information.

Because the evidence-based method of guideline development pioneered by AHCPR has become well accepted, and because there are now many public and private organizations that develop clinical practice guidelines, AHCPR no longer sponsors development of guidelines. Instead, the Agency supports Evidence-based Practice Centers (EPCs) to conduct syntheses of the scientific evidence on clinical topics of national significance that enable clinicians and health care organizations to develop their own quality improvement initiatives. AHCPR also participates in a public-private partnership with the American Medical Association and the American Association of Health Plans has created the National Guideline Clearinghouse™. The Clearinghouse is a comprehensive, Internet-based source for clinical practice guidelines and related materials.

AHCPR has sponsored research on several issues related to services for aged, blind, and disabled Medicaid recipients. For example:

Return to Contents

Maternal and Child Health

Although the aged, blind, and disabled account for the largest share of program costs, most Medicaid recipients are poor children and their mothers. About half of all Medicaid recipients are children and as noted earlier, Medicaid pays for about a third of all births in the United States. AHCPR research has indicated many ways that Medicaid, and other providers of care to children and pregnant women, can increase quality and reduce costs. For example:

Return to Contents

Research and Technical Assistance on HIV and AIDS

Currently the Medicaid program finances care for 53 percent of all persons living with AIDS (PLWA) and up to 90 percent of all children with AIDS. Medicaid is the largest single payer of direct medical services to PLWAs. Estimated combined Federal and State Medicaid expenditures will be $3.3 billion in fiscal year 1997 (Personal Communication, Joseph Dunne, Health Care Financing Administration, April 28, 1997). AHCPR has sponsored over 100 research projects to help State Medicaid programs control costs and improve quality in care for HIV and AIDS patients. For example:

Return to Contents

Drug Policy

Between 1984 and 1993, Medicaid pharmaceutical expenses increased fourfold from $1.97 billion a year to $7.97 billion. For this reason, evaluations of State cost-control efforts in the pharmaceutical area can be very helpful to States. Because of considerable State interest in this issue, in 1995 AHCPR sponsored a workshop on Medicaid drug utilization review for State Medicaid directors and members of State drug utilization review boards. In addition, the Agency has sponsored research focusing on the effectiveness of various mechanisms designed to control drug costs. For example:

Return to Contents

Informing Consumers

In the context of AHCPR's efforts to provide information that assists consumers in making choices among health plans, AHCPR has targeted a number of its efforts for Medicaid recipients.

Return to Contents

System Financing and Management

Finally, rapid changes in public programs and private markets have created new challenges for States that cut across programmatic lines: how to work with private-sector plans, how to measure and monitor quality, how to achieve greater cost-effectiveness, and how to structure financial incentives in a way that supports quality care. AHCPR has conducted a variety of research initiatives and technical assistance programs designed to support States in these efforts. For example:

Return to Contents

Conclusion

The Medicaid program is likely to undergo considerable change in the future. State responsibility for financing and delivery of care for poor and vulnerable populations is likely to increase, and therefore States will have an increased need for research, measurement tools, and technical assistance programs to help them improve access, enhance quality, and control costs. AHCPR will need to work closely with HCFA and the States to ensure that the Agency's future research and technical assistance efforts respond to these changing State needs.

Return to Contents

References

Agency for Health Care Policy and Research. Real world use of guidelines. AHCPR Pub. No. 96-R034. Rockville, MD: AHCPR, March 12, 1996a.

Agency for Health Care Policy and Research. Assessing roles, responsibilities, and activities in a managed care environment: A workbook for local health officials. AHCPR Pub. No. 96-0057. Rockville, MD: AHCPR, July 1996b.

Agency for Health Care Policy and Research. Better quality can cost less: The evolving role of AHCPR. Interim Report to the National Advisory Council. AHCPR Pub. No. 95-R011. Rockville, MD: AHCPR, September 1995a.

Agency for Health Care Policy and Research. Pregnancy and HIP Is AZT the Right Choice for You and Your Baby? AHCPR Pub. No. 96-0007. AHCPR, Rockville, MD, December 1995b.

Agency for Health Care Policy and Research. Low Income Children: The Effect of Expanding Medicaid on Well-Child Visits. Intramural Research Highlights, No. 38. AHCPR Pub. No. 94-0137. Rockville, MD: AHCPR, June 1994.

Bennett CL, et al. Costs of terminal care for people with AIDS. AIDS Patient Care, February 1995: 7-9.

Buchanan RJ, Kircher FG. Medicaid policies for AIDS-related hospital care. Health Care Financing Rev 1994; 15(4): 33-41.

Chiang YP, Bassi LJ, and Javitt JC. Federal budgetary costs of blindness. Milbank Quarterly Review 1992; 70(2): 319-40.

Cohen JW, and Cunningham PJ. Medicaid physician fee levels and children's access to care. Health Afiirs Spring 1995; 14(1): 255-262.

Cohen JW, and Spector, WD. The effect of Medicaid reimbursement on quality of care in nursing homes. Journal of Health Economics 1996; 15: 23-48.

Elixhauser A, Weschler JM, Kitzmiller JL, et al. Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care 1993; 16(8): 1146-57.

Gadomski AM, et al. Diverting managed care Medicaid patients from pediatric emergency department use. Pediatrics February 1995; 95(2): 170-178.

Gallant JE, McAvinue SM, Moore RD, et al. The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia. Chest 1995; 107(4): 1018-23.

Ginsburg KR, Slap GB, Cnaan A, et al. Adolescents' perceptions of factors affecting their decisions to seek health care. JAMA 1995; 273(24): 1913-18.

Javitt JC, Aiello LP, Chiang Y, et al. Preventive eye care in people with diabetes is cost-saving to the Federal government: Implications for health reform. Diabetes Care 1994; 17(8): 909-17.

Lair TJ. A profile of 1987 nursing home users under 65. National Medical Expenditure Survey Research Findings 13. AHCPR Pub. No. 92-0060. Rockville, MD: Agency for Health Care Policy and Research, 1992.

Lieu TA, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271(5): 375-381.

Lewin VHI, Rubin R, Gold W, et al. Otitis media in 2-year olds: Current treatment patterns and estimated costs of practice guidelines. Appendix I: cost report. In Stool SE, Berg AO, Berman S, et al. Otitis media with effusion in young children. Guideline Technical Report, No. 12. AHCPR Pub. No. 95-0621. Rockville, MD: Agency for Health Care Policy and Research, 1994.

Rowland D. Medicaid: The health and long-term care safety net. Testimony before the Committee on Finance, United States Senate, June 29, 1995.

Rowland D. Hanson K. Medicaid: Moving to Managed Care. Health Affairs Fall 1996; 15(3): 150-152.

Short PF, et al. Public and private responsibility for financing nursing home care: The effect of Medicaid asset spend-down. Milbank Quarterly Review 1992; 70(2): 277-298.

Smalley WE, Griffin MR. Effect of a prior-authorization requirement for nonsteroidal anti-inflammatory drugs by Medicaid patients. NEngl JMed 1995; 332(24): 1612-17.

Smith JA, Kinney TR, Ames B, et al. Sickle Cell Disease: Screening, Diagnosis, Management, and Counseling in Newborns and Infants. Clinical Practice Guideline No. 6. AHCPR Pub. No. 93-0562. Rockville, MD: Agency for Health Care and Policy and Research, April 1993.

Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effects of limiting drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994; 331(10): 650-5.

Soumerai S, et al. Payment restrictions for prescription drugs under Medicaid: Effects on therapy, cost, and equity. N Engl J Med 1987; 317(9): 550-556.

Starfield B, Powe NO, Wiener JR, et al. Costs vs. quality in different types of primary care settings. JAMA Dec 28, 1994; 272(24): 1903-1908.

Return to Contents

AHCPR Publication No. 97-0044
Current as of August 1997


Internet Citation:

Meeting Medicaid's Cost and Quality Challenges: The Role of AHCPR Research. AHCPR Program Note. AHCPR Publication No. 97-0044, August 1997. Agency for Health Care Policy and Research, Rockville, MD. http://www.ahrq.gov/research/mednote.htm


Return to Healthcare Costs
Research Findings
AHRQ Home Page
Department of Health and Human Services